• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 3. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755

Recent Advances in the Application of Methyl 2-Bromo-4-methylpyridine-3-carboxylate (CAS: 313070-65-4) in Chemical Biology and Pharmaceutical Research

Methyl 2-bromo-4-methylpyridine-3-carboxylate (CAS: 313070-65-4) is a key intermediate in the synthesis of various biologically active compounds. Recent studies have highlighted its significance in medicinal chemistry, particularly in the development of novel therapeutic agents. This compound serves as a versatile building block for the construction of complex heterocyclic structures, which are often found in drugs targeting infectious diseases, cancer, and neurological disorders. The bromo and ester functional groups present in this molecule provide multiple sites for further chemical modifications, enabling the creation of diverse derivatives with potential pharmacological activities.

In a recent study published in the Journal of Medicinal Chemistry, researchers utilized methyl 2-bromo-4-methylpyridine-3-carboxylate as a precursor for the synthesis of a series of pyridine-based kinase inhibitors. The study demonstrated that the bromo substituent at the 2-position of the pyridine ring played a critical role in enhancing the binding affinity of the inhibitors to their target kinases. The researchers employed a combination of computational modeling and synthetic chemistry to optimize the structure-activity relationship (SAR) of the derivatives, leading to the identification of several promising candidates with potent inhibitory activity against cancer-associated kinases.

Another significant application of methyl 2-bromo-4-methylpyridine-3-carboxylate was reported in the field of antimicrobial drug development. A research team from the University of Cambridge explored its use in the synthesis of novel quinolone derivatives. The bromo group facilitated the introduction of various substituents via palladium-catalyzed cross-coupling reactions, resulting in compounds with broad-spectrum antibacterial activity. The study highlighted the importance of the methyl ester group in improving the pharmacokinetic properties of the final drug candidates, such as solubility and metabolic stability.

Recent advancements in synthetic methodologies have also expanded the utility of methyl 2-bromo-4-methylpyridine-3-carboxylate. A paper in Organic Letters described a novel one-pot synthesis approach that significantly reduced the number of steps required to convert this intermediate into complex heterocycles. This method not only improved the overall yield but also minimized the generation of hazardous waste, aligning with the principles of green chemistry. The authors emphasized the potential of this approach for large-scale production of pharmaceutical intermediates.

In addition to its applications in drug discovery, methyl 2-bromo-4-methylpyridine-3-carboxylate has been investigated as a tool compound in chemical biology. A study published in ACS Chemical Biology utilized this molecule as a starting material for the synthesis of fluorescent probes targeting specific enzymes involved in neurodegenerative diseases. The probes enabled real-time monitoring of enzyme activity in live cells, providing valuable insights into disease mechanisms and facilitating the development of targeted therapies.

Despite its widespread use, challenges remain in the handling and storage of methyl 2-bromo-4-methylpyridine-3-carboxylate due to its sensitivity to moisture and light. Recent efforts have focused on developing more stable formulations and improved storage conditions to ensure the integrity of the compound during long-term use. These advancements are expected to further enhance its utility in both academic and industrial research settings.

In conclusion, methyl 2-bromo-4-methylpyridine-3-carboxylate (CAS: 313070-65-4) continues to be a valuable intermediate in chemical biology and pharmaceutical research. Its versatility, combined with recent methodological improvements, has opened new avenues for the development of therapeutic agents and chemical tools. Future research is likely to explore its potential in emerging areas such as targeted protein degradation and covalent inhibitor design, further solidifying its role in drug discovery and development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)